On Tuesday, October 12th, the college of pharmacy hosted a research webinar by Dr. Eslam Mohamed, Assistant professor of Immunology at California Northstate University, CA, USA. Dr. Eslam earned his Ph.D. degree in the field of immunology and immunological programming, from the Medical College of Georgia in Augusta, GA, USA in 2016. Afterwards, Dr. Mohamed pursued a postdoctoral fellowship at Moffitt Cancer center in Tampa, FL where he explored some potential mechanisms that govern the suppressive phenotype of tumor associated myelopoiesis and developed therapeutic interventions to promote an effective antitumor immunity.
The talk focused on of Dr. Eslam’s latest publication published in Cell Press Journal on “Targeting ER stress as a promising strategy to reprogram immunosuppressive myelopoiesis in the tumor microenvironment”. He presented on the novel emerging field of Cancer and emergency myelopoiesis and how tumor can reprogram the infiltrating myeloid cells to promote their own progression and suppress the effector antitumor immune responses.
The webinar was attended by GMU Master in Drug Discovery & Development (MDD) students who were intrigued by the field of immunological programming and designing anticancer treatments.
Dr. Ahmed Thabet, the director of the MDD program and chair of the department of pharmaceutical sciences commented: “It is always a pleasure to have unique speakers in our MDD seminar series especially those who have a scope of work that can positively impact the current research trends at the college of pharmacy”.